Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Efficacy and tolerability of latanoprost compared with timolol in the treatment of patients with chronic angle-closure glaucoma.

Lou H, Zong Y, Ge YR, Cheng JW, Wei RL.

Curr Med Res Opin. 2014 Jul;30(7):1367-73. doi: 10.1185/03007995.2014.905825. Epub 2014 Mar 27. Review.

PMID:
24641069
2.
3.

Meta-analysis of randomized controlled trials comparing latanoprost with timolol in the treatment of Asian populations with chronic angle-closure glaucoma.

Li SM, Chen R, Li Y, Yang ZR, Deng QJ, Zhong Z, Ong ML, Zhan SY.

PLoS One. 2014 May 9;9(5):e96852. doi: 10.1371/journal.pone.0096852. eCollection 2014.

4.
5.

Meta-analysis of randomized controlled trials comparing latanoprost with other glaucoma medications in chronic angle-closure glaucoma.

Li J, Lin X, Yu M.

Eur J Ophthalmol. 2015 Jan-Feb;25(1):18-26. doi: 10.5301/ejo.5000506. Epub 2014 Jul 8.

PMID:
25044139
6.

Efficacy and tolerability of prostaglandin-timolol fixed combinations: an updated systematic review and meta-analysis.

Lou H, Wang H, Zong Y, Cheng JW, Wei RL.

Curr Med Res Opin. 2015 Jun;31(6):1139-47. doi: 10.1185/03007995.2015.1039504. Review.

PMID:
25867658
7.

Intraocular pressure-reducing effects of latanoprost versus timolol in chinese patients with chronic angle-closure glaucoma.

Zhao J, Ge J, Sun X, Wang N.

J Glaucoma. 2013 Sep;22(7):591-6. doi: 10.1097/IJG.0b013e31825af33e.

PMID:
22706336
9.

Intraocular pressure-lowering effect of adding dorzolamide or latanoprost to timolol: a meta-analysis of randomized clinical trials.

Webers CA, van der Valk R, Schouten JS, Zeegers MP, Prins MH, Hendrikse F.

Ophthalmology. 2007 Jan;114(1):40-6. Epub 2006 Oct 27.

PMID:
17070584
10.

A meta-analysis of topical prostaglandin analogs in the treatment of chronic angle-closure glaucoma.

Cheng JW, Cai JP, Li Y, Wei RL.

J Glaucoma. 2009 Dec;18(9):652-7. doi: 10.1097/IJG.0b013e31819c49d4.

PMID:
20010242
11.
12.

Efficacy and tolerability of prostaglandin-timolol fixed combinations: a meta-analysis of randomized clinical trials.

Aptel F, Cucherat M, Denis P.

Eur J Ophthalmol. 2012 Jan-Feb;22(1):5-18. doi: 10.5301/ejo.5000009.

PMID:
22167538
13.

Intraocular pressure-reducing effects and safety of latanoprost versus timolol in patients with chronic angle-closure glaucoma.

Chew PT, Aung T, Aquino MV, Rojanapongpun P; EXACT Study Group.

Ophthalmology. 2004 Mar;111(3):427-34.

PMID:
15019314
14.
17.
18.

Comparison of latanoprost monotherapy and combined therapy of 0.5% timolol and 1% dorzolamide in chronic primary angle-closure glaucoma (CACG) in Japanese patients.

Sakai H, Shinjyo S, Nakamura Y, Nakamura Y, Ishikawa S, Sawaguchi S.

J Ocul Pharmacol Ther. 2005 Dec;21(6):483-9.

PMID:
16386090
19.

Efficacy of latanoprost in reducing intraocular pressure in patients with primary angle-closure glaucoma.

Chew PT, Hung PT, Aung T.

Surv Ophthalmol. 2002 Aug;47 Suppl 1:S125-8.

PMID:
12204708
20.

Peak pressures: crossover study of timolol and latanoprost.

Sihota R, Saxena R, Agarwal HC, Pandey RM, Gulati V.

Eur J Ophthalmol. 2003 Jul;13(6):546-52.

PMID:
12948313
Items per page

Supplemental Content

Write to the Help Desk